The direct detection of gonococcal DNA in rectal and pharyngeal specimens was evaluated by using a DNA probe-based assay (Gen-Probe, Inc., San Diego, Calif.). Rectal (234) and pharyngeal (608) The laboratory diagnosis of gonococcal pharyngeal and rectal infections is usually achieved by the isolation of Neisseria gonorrhoeae on selective media, followed by confirmatory identification (2). Because these sites often harbor other bacterial species, which may be misidentified as N. gonorrhoeae, a variety of biochemical and immunological tests have been developed to aid in the culture confirmation of N. gonorrhoeae (3, 7).
The laboratory diagnosis of gonococcal pharyngeal and rectal infections is usually achieved by the isolation of Neisseria gonorrhoeae on selective media, followed by confirmatory identification (2) . Because these sites often harbor other bacterial species, which may be misidentified as N. gonorrhoeae, a variety of biochemical and immunological tests have been developed to aid in the culture confirmation of N. gonorrhoeae (3, 7) .
An alternative nonculture system (PACE 2; Gen-Probe, Inc., San Diego, Calif.) in widespread use for detecting N. gonorrhoeae in cervical and urethral specimens has been reported to be accurate in studies in which parallel testing of duplicate samples was performed (5, 11, 13) . This method detects the presence of gonococcal rRNA in patient specimens with an acridinium ester-labeled DNA probe coupled with a chemiluminescent detection system.
Studies involving the testing of specimens from sites other than the urethra and cervix for N. gonorrhoeae and using DNA canal. Pharyngeal specimens were collected by rigorous swabbing of the posterior pharynx, including the tonsillar areas. The order of swab collection was rotated on a weekly basis to minimize the overall effect of specimen variation and collection. Plated specimens were cross-streaked and incubated for 48 h at 35°C in a humidified atmosphere supplemented with carbon dioxide. Isolates were identified by standard procedures, i.e., Gram staining, oxidase reaction, and colony morphology. Presumptively positive isolates were confirmed by monoclonal fluorescent-antibody tests (Bartels Diagnostics, Bellevue, Wash.). All nongonococcal isolates were identified by relevant biochemical tests and any additional bacteriologic procedures as necessary (12) .
Specimens collected for DNA probe testing were transported by mail from the collection sites to Atlanta, Ga., and tested within 1 week. The results of the DNA probe test are calculated based on the difference between the response in relative light units (RLU) of the specimen and the mean RLU of three negative control values. If the specimen signal exceeded the mean of the negative references by 300 RLU (cutoff), the sample was considered positive. A probe competition confirmatory test was performed at the Centers for Disease Control, Atlanta, Ga., on specimens yielding dis- (Table 1) . When retested with the probe competition assay, both specimens were confirmed as N. gonorrhoeae positive; i.e., the probe competition assay verified the presence of gonococcal nucleic acid in both of these samples. In addition, both of these patients were contacts of men diagnosed as having gonococcal urethral infections, strongly indicating these two specimens were false-negative culture results. The sensitivity of the DNA probe test was 87.5% after resolution of these two samples. No probe-positive, culture-negative specimens were observed in the pharyngeal samples obtained from men (Table 2) . However, the DNA probe test did not detect two samples that were confirmed culture positive, yielding a test sensitivity of 71.4% (5 of 7 specimens).
The prevalence of rectal gonococcal infections as determined by culture was 4.7% (11 of 234 specimens). The majority of positive cultures (10 of 11) occurred in women. The sensitivity and specificity of the DNA probe test in both men and women was 100% compared with those of gonococcal culture (Table 3) . Results shown in Table 4 illustrate the wide range of RLU readings obtained between the mean values of the gonococcal isolates (men, 3,426 RLU; women, 13,423 RLU), and the nongonococcal isolates (men, 72 RLU; women, 56 RLU). Most of the gonococcal isolates gave readings that were 2 to 3 orders of magnitude greater than those of the nongonococcal isolates tested.
Pharyngeal gonorrhea is usually asymptomatic but can be a source for disseminated disease and may persist with or N. gonorrhoeae (13) 610-12,328 [3, 426] 611-61,012 [13, 423 ] N. menigitidis (13) 46 (9, (13) (14) (15) . Several studies have suggested that fewer than 10% of anorectal gonococcal infections are symptomatic (10) . The DNA probe assay results were in complete agreement with culture results on all 234 rectal specimens tested.
Again, as with the pharyngeal specimens, the total number of positive rectal specimens was low. Although further studies with larger number of positive specimens are needed, the excellent performance of the probe assay presented here strongly indicates the utility of the assay for rectal specimens. The PACE 2 assay, although not currently approved for use with pharyngeal or rectal specimens, appears promising for the testing of these nongenital sites.
